Lipoprotein-associated phospholipase testing for coronary heart disease risk assessment in healthy or asymptomatic adults
Record ID 32011000889
English
Authors' objectives:
Lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular inflammatory enzyme, has been investigated as a surrogate biomarker of increased coronary heart disease (CHD) risk. Lp-PLA2 testing has been used as an adjunct to conventional CHD risk assessment in healthy or asymptomatic individuals to determine who might benefit from specific risk-reducing interventions, such as pharmacological therapies and behavior modification strategies.
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=11917
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- 1-Alkyl-2-acetylglycerophosphocholine Esterase
- Biomarkers
- Cardiovascular Diseases
- Risk Assessment
- Risk Factors
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.